Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
27 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: colchicine
Active substance: rivaroxaban
Active substance: dabigatran etexilate mesilate
Active substance: rivaroxaban
Active substance: rivaroxaban
Active substance: apixaban
Active substance: edoxaban tosilate
Active substance: edoxaban tosilate
Active substance: clopidogrel (as hydrogen sulfate)
Active substance: apixaban
Active substance: clopidogrel (as hydrochloride)
Active substance: telmisartan
Active substance: clopidogrel besilate
Active substance: clopidogrel (as hydrogen sulfate)
Active substance: clopidogrel (as hydrochloride)
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
2.4 billion people live with a condition that could benefit from rehabilitation. The need rose 63% since 1990.
Read
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.